Junjian B. Wang
132 East Waihuan Road
Guangzhou, 510006, China
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Dual-Site Covalent Targeting Enables BD2-Selective BET Inhibition With Potent Antitumor Activity in Mice.
Journal: Angewandte Chemie (International ed. in English)
Published: April 04, 2026
Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer.
Journal: Journal of medicinal chemistry
Published: March 20, 2026
O-GlcNAcylation of NSD2 promotes lung metastasis of triple-negative breast cancer through extracellular matrix remodeling.
Journal: Biochemical and biophysical research communications
Published: January 30, 2026
Cytotoxic Cytochalasans from Sponge-Derived Aspergillus sp. SCSIO 41044.
Journal: Molecules (Basel, Switzerland)
Published: October 10, 2025
Oxalicpyridones A-D, 2-pyridone alkaloids from a marine-derived fungus Penicillium oxalicum suppressing proliferation and metastasis against small cell lung cancer.
Journal: Phytochemistry
Published: July 24, 2025
Phase separation of RXRγ drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 20, 2025
RORγ Hijacks HIF1α to Promote Peritoneal Metastasis of Gastric Cancer.
Journal: Cancer research
Published: April 18, 2025
Androgen receptor acts as the transcriptional repressor of the nuclear receptor LRH-1 via the androgen-driven chromatin looping conformation in prostate cancer.
Journal: Genes & diseases
Published: February 12, 2025
Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation.
Journal: Journal of medicinal chemistry
Published: November 13, 2024
Corrigendum to "Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation" [Pharmacol. Res. 159 (2020) 104944].
Journal: Pharmacological research
Published: October 24, 2024
Correction to "Discovery of a Highly Potent Lysine Methyltransferases G9a/NSD2 Dual Inhibitor to Treat Solid Tumors".
Journal: Journal of medicinal chemistry
Published: October 15, 2024
Last Updated: 09/26/2026